Vivani Medical, Inc.(VANI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

VANI Vivani Medical, Inc.

Post-Mkt 04-10 19:08:01 EDT

1.04

+0.00

0.00%

盘后1.01

-0.03-2.88%

17:00 EDT

High1.06	Low1.01	Vol115.31K
Open1.06	D1 Closing1.04	Amplitude4.81%
Mkt Cap88.03M	Tradable Cap39.28M	Total Shares84.65M
T/O118.96K	T/O Rate0.31%	Tradable Shares37.77M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"VANI","market":"US","secType":"STK","nameCN":"Vivani Medical, Inc.","latestPrice":1.04,"timestamp":1775851200000,"preClose":1.04,"halted":0,"volume":115308,"hourTrading":{"tag":"盘后","latestPrice":1.01,"preClose":1.04,"latestTime":"17:00 EDT","volume":232,"amount":240.42999840000002,"timestamp":1775854809763,"change":-0.03,"changeRate":-0.028846,"amplitude":0.028846},"delay":0,"changeRate":0,"floatShares":37769679,"shares":84647800,"eps":-0.426501,"marketStatus":"Post-Mkt","change":0,"latestTime":"04-10 19:08:01 EDT","open":1.06,"high":1.06,"low":1.01,"amount":118957.3713612,"amplitude":0.048077,"askPrice":1.18,"askSize":50,"bidPrice":0.9145,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.426501,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1775865600000},"marketStatusCode":4,"adr":0,"listingDate":1416373200000,"exchange":"NASDAQ","adjPreClose":1.04,"postHourTrading":{"tag":"盘后","latestPrice":1.01,"preClose":1.04,"latestTime":"17:00 EDT","volume":232,"amount":240.42999840000002,"timestamp":1775854809763,"change":-0.03,"changeRate":-0.028846,"amplitude":0.028846},"volumeRatio":0.981808,"impliedVol":0.9718,"impliedVolPercentile":0.304},"requestUrl":"/m/hq/s/VANI","defaultTab":"news","newsList":[{"id":"2624564272","title":"Vivani Medical Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2624564272","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624564272?lang=en_us&edition=fundamental","pubTime":"2026-04-01 14:02","pubTimestamp":1775023320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VANI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 01, 2026 02:02 ET (06:02 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VANI","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624535227","title":"Vivani Medical price target lowered to $3.50 from $4 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2624535227","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624535227?lang=en_us&edition=fundamental","pubTime":"2026-03-31 23:51","pubTimestamp":1774972313,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Yi Chen lowered the firm’s price target on Vivani Medical (VANI) to $3.50 from $4 and keeps a Buy rating on the shares afte...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vivani-medical-price-target-lowered-to-3-50-from-4-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vivani-medical-price-target-lowered-to-3-50-from-4-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VANI","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622162803","title":"Vivani Medical Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2622162803","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622162803?lang=en_us&edition=fundamental","pubTime":"2026-03-28 05:03","pubTimestamp":1774645394,"startTime":"0","endTime":"0","summary":"Vivani Medical Inc reports results for the quarter ended December 31 - Earnings SummaryVivani Medical Inc VANI.OQ reported a quarterly adjusted loss of 9 cents per share for the quarter ended December","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nL8N40F23E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VANI","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622740899","title":"Vivani Medical Q4 EPS $(0.09) Beats $(0.10) Estimate.","url":"https://stock-news.laohu8.com/highlight/detail?id=2622740899","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622740899?lang=en_us&edition=fundamental","pubTime":"2026-03-27 04:49","pubTimestamp":1774558173,"startTime":"0","endTime":"0","summary":"Vivani Medical (NASDAQ:VANI) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.10) by 10 percent. This is a 18.18 percent increase over losses of $(0.11) per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51496998/vivani-medical-q4-eps-0-09-beats-0-10-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Vivani Medical Q4 EPS $(0.09) Beats $(0.10) Estimate.","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VANI","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622896708","title":"Vivani Medical FY2025 net loss widens 13.2% to $26.6 million; loss per share holds at $0.43","url":"https://stock-news.laohu8.com/highlight/detail?id=2622896708","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622896708?lang=en_us&edition=fundamental","pubTime":"2026-03-27 04:18","pubTimestamp":1774556339,"startTime":"0","endTime":"0","summary":"Vivani published a press release reporting Q4 and full-year 2025 financial results and a business update .Q4 net loss was USD 6.6 million, while R&D expense rose 7% to USD 4.6 million.FY net loss was USD 26.6 million and R&D expense increased 15% to USD 18.1 million, driven by higher clinical-trial and development spending in the biopharm division.FY G&A expense increased 6% to USD 9.4 million, primarily due to higher professional services costs across the neurostimulation and biopharm divisions.Cash and cash equivalents were USD 16.2 million at year-end, and management said cash, equivalents and commitments are expected to fund operations into mid-2027 as it targets initiation of a Phase 1 feasibility study of NPM-139 in mid-2026 with results anticipated by the end of 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDLqfJV9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","VANI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619635451","title":"Vivani Medical Director Gregg Williams reports acquisition of Vivani Medical common shares worth USD 1.68 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2619635451","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619635451?lang=en_us&edition=fundamental","pubTime":"2026-03-16 18:16","pubTimestamp":1773656183,"startTime":"0","endTime":"0","summary":"Gregg Williams, a director and 10% owner of Vivani Medical, reported acquiring 1,575,231 common shares through private purchase transactions. The shares were acquired at prices of USD 1.03 and USD 1.26 per share. Following the acquisitions, Williams reported indirect beneficial ownership of 31,357,183 common shares. Williams also reported direct ownership of 4,799,200 common shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivani Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 16, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nNDL46pdFR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Vivani Medical Director Gregg Williams reports acquisition of Vivani Medical common shares worth USD 1.68 million","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","VANI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612135456","title":"Director and 10% Owner Gregg Williams Acquires Common Shares of Vivani Medical Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2612135456","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612135456?lang=en_us&edition=fundamental","pubTime":"2026-02-17 19:12","pubTimestamp":1771326752,"startTime":"0","endTime":"0","summary":"Gregg Williams, a director and 10% owner, reported the acquisition of common shares of Vivani Medical Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivani Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 17, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nNDL8sqKNR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Director and 10% Owner Gregg Williams Acquires Common Shares of Vivani Medical Inc","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VANI","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607084077","title":"Cortigent Reports Promising Six-Year Results for Orion Visual Prosthesis","url":"https://stock-news.laohu8.com/highlight/detail?id=2607084077","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607084077?lang=en_us&edition=fundamental","pubTime":"2026-01-29 20:30","pubTimestamp":1769689849,"startTime":"0","endTime":"0","summary":"Vivani Medical Inc. announced that its wholly-owned subsidiary, Cortigent, Inc., presented promising six-year early feasibility study results for the Orion Visual Cortical Prosthesis System at the North American Neuromodulation Society annual meeting. Cortigent is a leading developer of brain implant devices based on precision neurostimulation technology and is the only company to have obtained FDA approval of a device providing artificial vision for the profoundly blind. In addition to the Orion system, Cortigent is developing a new medical device aimed at improving recovery of arm and hand motion in patients with paralysis due to stroke.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivani Medical Inc. published the original content","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nNDL35NhpV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","LU2210150020.SGD","BK4585","SG9999014013.SGD","IE00BGHQF748.EUR","CRGT","BK4082","IE00BKPKM429.USD","SG9999014005.SGD","LU2095319765.USD","SG9999014039.USD","LU0314104364.USD","LU2210149790.SGD","IE00B3QW5Z07.USD","VANI","NDAQ","BK4588","IE00B64PRP62.GBP","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606715710","title":"Vivani Medical Director and 10% Owner Gregg Williams Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2606715710","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606715710?lang=en_us&edition=fundamental","pubTime":"2026-01-28 23:01","pubTimestamp":1769612515,"startTime":"0","endTime":"0","summary":"Gregg Williams, a Director and 10% Owner of Vivani Medical Inc., has reported the acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivani Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 28, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nNDL1dTSSC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Vivani Medical Director and 10% Owner Gregg Williams Reports Acquisition of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VANI","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606588697","title":"Vivani Medical, Inc. Announces Closing of Common Stock Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2606588697","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606588697?lang=en_us&edition=fundamental","pubTime":"2026-01-28 05:05","pubTimestamp":1769547901,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260127:nTUA6MNLKW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VANI","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606429534","title":"BRIEF-Vivani Medical Announces Pricing Of Common Stock Offering At $1.48 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2606429534","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606429534?lang=en_us&edition=fundamental","pubTime":"2026-01-26 12:37","pubTimestamp":1769402242,"startTime":"0","endTime":"0","summary":"BRIEF-Vivani Medical Announces Pricing Of Common Stock Offering At $1.48 Per ShareJan 25 (Reuters) - Vivani Medical Inc VANI.O:VIVANI MEDICAL, INC. ANNOUNCES PRICING OF COMMON STOCK OFFERINGVIVANI MED","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nTUATL1C8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VANI","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606295343","title":"Vivani Medical Inc - Prices Direct Offering of 1,689,200 Shares at $1.48","url":"https://stock-news.laohu8.com/highlight/detail?id=2606295343","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606295343?lang=en_us&edition=fundamental","pubTime":"2026-01-26 12:36","pubTimestamp":1769402187,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nTUATL1C8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","VANI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605649541","title":"Vivani subsidiary to present poster on Orion Visual Cortical Prosthesis System","url":"https://stock-news.laohu8.com/highlight/detail?id=2605649541","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605649541?lang=en_us&edition=fundamental","pubTime":"2026-01-22 20:18","pubTimestamp":1769084285,"startTime":"0","endTime":"0","summary":"Vivani Medical (VANI) announced that its wholly-owned subsidiary Cortigent will present an poster detailing the technical aspects of its Orion Visu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vivani-subsidiary-to-present-poster-on-orion-visual-cortical-prosthesis-system-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vivani-subsidiary-to-present-poster-on-orion-visual-cortical-prosthesis-system-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VANI","BK4082","CRGT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605495652","title":"Vivani Subsidiary Cortigent to Present Orion System’s Advanced Brain Implant Technology in Poster Session at NANS 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2605495652","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605495652?lang=en_us&edition=fundamental","pubTime":"2026-01-22 20:00","pubTimestamp":1769083200,"startTime":"0","endTime":"0","summary":"Cortigent is a leading developer of brain interface devices based on precision neurostimulation technology The company’s new Orion cortical stimulation system for visual perception, designed to treat ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/22/3223600/0/en/Vivani-Subsidiary-Cortigent-to-Present-Orion-System-s-Advanced-Brain-Implant-Technology-in-Poster-Session-at-NANS-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VANI","IE00B7SZL793.SGD","CRGT","LU0648000940.SGD","BK4588","LU0130518102.USD","BK4009","LU0130103400.USD","AEIS","LU1201861165.SGD","BK4585","IE00B66KJ199.SGD","LU0757428866.USD","BK4157","IE0031619046.USD","LU0477156797.USD","BK4082","IPG","LU1815336091.USD","IE00B19Z4B17.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604876119","title":"Director and 10% Owner Gregg Williams Reports Acquisition of Vivani Medical Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2604876119","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604876119?lang=en_us&edition=fundamental","pubTime":"2026-01-20 22:01","pubTimestamp":1768917685,"startTime":"0","endTime":"0","summary":"Gregg Williams, a Director and 10% Owner of Vivani Medical Inc., has reported the acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivani Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 20, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nNDL1Jj7rv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Director and 10% Owner Gregg Williams Reports Acquisition of Vivani Medical Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VANI","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595772504","title":"Vivani Medical Director Aaron Mendelsohn Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2595772504","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595772504?lang=en_us&edition=fundamental","pubTime":"2025-12-31 22:01","pubTimestamp":1767189666,"startTime":"0","endTime":"0","summary":"Aaron Mendelsohn, Director at Vivani Medical Inc., reported an acquisition of common shares of Vivani Medical Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivani Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 31, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251231:nNDL1B161S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Vivani Medical Director Aaron Mendelsohn Reports Acquisition of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","VANI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2591198085","title":"Director and 10% Owner Gregg Williams Acquires Common Shares of Vivani Medical Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2591198085","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591198085?lang=en_us&edition=fundamental","pubTime":"2025-12-16 22:00","pubTimestamp":1765893649,"startTime":"0","endTime":"0","summary":"Gregg Williams, a Director and 10% Owner, reported the acquisition of common shares of Vivani Medical Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivani Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 16, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nNDL9Zph3V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Director and 10% Owner Gregg Williams Acquires Common Shares of Vivani Medical Inc","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VANI","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586418184","title":"Vivani Medical Inc. unveils presentation on subdermal semaglutide implant for chronic weight management","url":"https://stock-news.laohu8.com/highlight/detail?id=2586418184","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586418184?lang=en_us&edition=fundamental","pubTime":"2025-11-25 05:45","pubTimestamp":1764020727,"startTime":"0","endTime":"0","summary":"Vivani Medical Inc. has published a presentation outlining its progress and strategy in the obesity and chronic disease treatment market. The company is developing NPM-139, a miniature, subdermal semaglutide implant designed for chronic weight management in obese and overweight individuals. Unlike currently approved GLP-1 therapies, which are available only as injectables or orals, Vivani's NanoPortal technology enables dosing every 6 to 12 months via a subdermal implant. The company reports that its LIBERATE-1 first-in-human study achieved its primary objectives, demonstrating positive safety, tolerability, and device performance. Vivani projects that its cash runway will extend through key milestones and into 2027, with the NPM-139 clinical program set to begin in the first half of 2026. The presentation also notes the growing GLP-1 market, which is expected to reach $139 billion by 2030. You can access the full presentation through the link below.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nNDL6yrhcx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VANI","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584226479","title":"Vivani Medical Q3 Net Income USD -6.53 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2584226479","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584226479?lang=en_us&edition=fundamental","pubTime":"2025-11-20 01:37","pubTimestamp":1763573867,"startTime":"0","endTime":"0","summary":"Nov 13 (Reuters) - Vivani Medical Q3 operating expenses USD 6.725 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 13-NOV-202512:37:19.477 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD7dW2WL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","VANI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584629172","title":"Director and 10% Owner Gregg Williams Reports Acquisition of Vivani Medical Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2584629172","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584629172?lang=en_us&edition=fundamental","pubTime":"2025-11-17 22:00","pubTimestamp":1763388058,"startTime":"0","endTime":"0","summary":"Gregg Williams, a Director and 10% Owner of Vivani Medical Inc., has reported the acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivani Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 17, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nNDL9MfTP7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Director and 10% Owner Gregg Williams Reports Acquisition of Vivani Medical Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VANI","BK4082"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vivani.com;investors.vivani.com","stockEarnings":[{"period":"1week","weight":-0.037},{"period":"1month","weight":-0.1111},{"period":"3month","weight":-0.218},{"period":"6month","weight":-0.2409},{"period":"1year","weight":-0.0095},{"period":"ytd","weight":-0.1545}],"compareEarnings":[{"period":"1week","weight":0.0367},{"period":"1month","weight":0.004},{"period":"3month","weight":-0.0204},{"period":"6month","weight":0.0412},{"period":"1year","weight":0.2393},{"period":"ytd","weight":-0.0029}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.416667,"avgChangeRate":-0.013761},{"month":2,"riseRate":0.333333,"avgChangeRate":0.262607},{"month":3,"riseRate":0.333333,"avgChangeRate":0.172227},{"month":4,"riseRate":0.416667,"avgChangeRate":0.006848},{"month":5,"riseRate":0.545455,"avgChangeRate":0.046981},{"month":6,"riseRate":0.454545,"avgChangeRate":-0.05177},{"month":7,"riseRate":0.454545,"avgChangeRate":-0.022536},{"month":8,"riseRate":0.272727,"avgChangeRate":-0.10962},{"month":9,"riseRate":0.636364,"avgChangeRate":-0.039438},{"month":10,"riseRate":0.272727,"avgChangeRate":-0.074632},{"month":11,"riseRate":0.363636,"avgChangeRate":-0.062683},{"month":12,"riseRate":0.333333,"avgChangeRate":0.011596}],"exchange":"NASDAQ","name":"Vivani Medical, Inc.","nameEN":"Vivani Medical, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Vivani Medical, Inc.(VANI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Vivani Medical, Inc.(VANI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Vivani Medical, Inc.,VANI,Vivani Medical, Inc.股票,Vivani Medical, Inc.股票老虎,Vivani Medical, Inc.股票老虎国际,Vivani Medical, Inc.行情,Vivani Medical, Inc.股票行情,Vivani Medical, Inc.股价,Vivani Medical, Inc.股市,Vivani Medical, Inc.股票价格,Vivani Medical, Inc.股票交易,Vivani Medical, Inc.股票购买,Vivani Medical, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Vivani Medical, Inc.(VANI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Vivani Medical, Inc.(VANI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}